Showing results (221-230 of 742) with videos related to

Sort By:
Pageof 75
JCO Oncology Practice|May 17, 2022
Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard CareSurbhi Sidana, Cristine Allmer, Melissa C Larson, et al.
Ejhaem|November 29, 2023
Late versus early response and depth of response are associated with improved outcomes in patients with newly diagnosed multiple myeloma enrolled in the TOURMALINE-MM2 trialPaul G Richardson, Thierry Facon, Christopher P Venner, et al.
British Journal of Haematology|February 16, 2019
Substratification of patients with newly diagnosed standard-risk multiple myelomaMoritz Binder, S Vincent Rajkumar, Rhett P Ketterling, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
Leukemia & Lymphoma|July 15, 2021
Treatment and outcome of newly diagnosed multiple myeloma patients > 75 years old: a retrospective analysisAbdullah S Al Saleh, Alissa Visram, Harsh Parmar, et al.
Transplantation and Cellular Therapy|April 11, 2021
Second Stem Cell Transplantation for Relapsed Refractory Light Chain (AL) AmyloidosisEli Muchtar, Angela Dispenzieri, Shaji K Kumar, et al.
Blood|August 16, 2017
Delineation of the timing of second-line therapy post-autologous stem cell transplant in patients with AL amyloidosisYi L Hwa, Rahma Warsame, Morie A Gertz, et al.
Blood|November 21, 2012
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myelomaP Leif Bergsagel, María-Victoria Mateos, Norma C Gutierrez, et al.
Blood Cancer Journal|February 16, 2023
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significanceAlexander J Ryu, Shaji Kumar, Angela Dispenzieri, et al.
American Journal of Cancer Research|August 15, 2022
Multiple myeloma with t(11;14): unique biology and evolving landscapeSusan Bal, Shaji K Kumar, Rafael Fonseca, et al.
Pageof 75